Personalized Medicine in Allergy.
- Author:
Matteo FERRANDO
1
;
Diego BAGNASCO
;
Gilda VARRICCHI
;
Stefano BERNARDI
;
Alice BRAGANTINI
;
Giovanni PASSALACQUA
;
Giorgio Walter CANONICA
Author Information
- Publication Type:Review
- Keywords: Personalized/precision medicine; allergy; monoclonal antibodies; omalizumab; mepolizumab
- MeSH: Antibodies, Monoclonal; Diagnostic Errors; Disease Management; Humans; Hypersensitivity*; Omalizumab; Pathology; Precision Medicine*; Prevalence
- From:Allergy, Asthma & Immunology Research 2017;9(1):15-24
- CountryRepublic of Korea
- Language:English
- Abstract: Allergic disease is among the most common pathologies worldwide and its prevalence has constantly increased up to the present days, even if according to the most recent data it seems to be slightly slowing down. Allergic disease has not only a high rate of misdiagnosis and therapeutic inefficacy, but represents an enormous, resource-absorbing black hole in respiratory and general medicine. The aim of this paper is to summarize principal therapeutic innovations in atopic disease management befallen in the recent years in terms of personalized/precision medicine.
